HKG Equity Snapshot
2566 Weekly Equity Report
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.
What the company does
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, manufacturing, and commercialization of biopharmaceutical products and medical devices in Mainland China and internationally. The company offers Guyoudao, a bone repair material; Jilifen, a human granulocyte colony stimulating factor injection; Jijufen, a human interleukin-11 injection; Jiouting, a palonosetron hydrochloride injection; Jifuwei, a fulvestrant injection; Jitansu, a fosaprepitant dimeglumine injection; and Jixinfen, PEG-GCSF injection. It also provides Jilixin avatrombopag maleate tablets; Jipailin, a low molecular weight heparin sodium injection; and Yinuojia, an enoxaparin sodium injection. The company was formerly known as Hangzhou …
What the weekly tape is saying
2566 closed the latest completed week at 5.20 HKD. The 4-week return is -24.0% and the 12-week return is -37.4%. Trend Signal is inactive, Market Dynamics is -1.00. Setup signature: Risk-first tape with a 12/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 7.80 HKD
- Vs Trend Line
- -33.4%
- Fair Value
- 8.10 HKD
- Vs Fair Value
- -35.8%
- 52W High
- 16.29 HKD
- 52W Low
- 5.09 HKD
- Drawdown
- -68.1%
- Range Position
- 1.0%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 19
- 52W Active Breadth
- 36.5%
- Sector Scope
- HK Healthcare
- Sector Rank
- 219 of 257
- Sector Percentile
- 14.8%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
HK Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- -1.3%
- Avg 4W
- -12.8%
- Trend Breadth
- 6.0%
- Positive MD
- 10.0%
HK Biotechnology
- Tracked Peers
- 76
- 4W Rank
- 56 of 76
- Avg 1W
- -1.6%
- Avg 4W
- -17.5%
- Trend Breadth
- 3.9%
- Positive RS
- 5.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.00
- 4W MD Change
- -1.6%
- Relative Strength
- -39.69
- 4W RS Change
- -54.9%
- Expectation
- Negative
- Probability
- 43.37%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 125.0K
- 13W Average
- 240.6K
- 52W Average
- 1.5M
- Vs 13W
- 0.5x
- Vs 52W
- 0.1x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 5.1%
- 52W Volatility
- 9.7%
- Upside Weeks
- 19
- Downside Weeks
- 33
- Downside Breadth
- 63.5%
- Avg Gain / Loss
- 8.4% / -6.2%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- HKG
- Country
- HK
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- HKD
- Market Cap
- 2.3B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 5.20 HKD | -7.3% | 7.80 HKD | 8.10 HKD | -1.00 | -39.69 | 125.0K | Off |
| 5 Jun 2026 | 5.61 HKD | -6.3% | 7.88 HKD | 8.14 HKD | -0.96 | -36.31 | 142.2K | Off |
| 29 May 2026 | 5.99 HKD | -7.6% | 7.94 HKD | 8.17 HKD | -0.95 | -32.71 | 417.2K | Off |
| 22 May 2026 | 6.48 HKD | -5.3% | 8.02 HKD | 8.20 HKD | -0.96 | -28.52 | 216.4K | Off |
| 15 May 2026 | 6.84 HKD | -2.1% | 8.11 HKD | 8.22 HKD | -0.99 | -25.62 | 281.2K | Off |
| 8 May 2026 | 6.99 HKD | -2.8% | 8.19 HKD | 8.24 HKD | -0.98 | -25.21 | 188.0K | Off |
| 1 May 2026 | 7.19 HKD | 4.2% | 8.30 HKD | 8.25 HKD | -0.92 | -21.23 | 132.6K | Off |
| 24 Apr 2026 | 6.90 HKD | -3.8% | 8.47 HKD | 8.27 HKD | -0.80 | -24.94 | 164.2K | Off |
| 17 Apr 2026 | 7.17 HKD | 1.7% | 8.61 HKD | 8.29 HKD | -0.61 | -22.58 | 216.0K | Off |
| 10 Apr 2026 | 7.05 HKD | 1.9% | 8.77 HKD | 8.30 HKD | -0.44 | -23.11 | 196.0K | Off |
| 3 Apr 2026 | 6.92 HKD | -12.8% | 8.96 HKD | 8.32 HKD | -0.32 | -22.23 | 711.2K | Off |
| 27 Mar 2026 | 7.94 HKD | -4.5% | 9.21 HKD | 8.34 HKD | -0.21 | -10.21 | 142.0K | Off |
| 20 Mar 2026 | 8.31 HKD | 6.1% | 9.39 HKD | 8.35 HKD | -0.08 | -7.15 | 196.4K | Off |
| 13 Mar 2026 | 7.83 HKD | -4.5% | 9.61 HKD | 8.35 HKD | 0.02 | -12.97 | 171.2K | Off |